# Phase I Study of Kukoamine B Mesilate in Healthy Volunteers

> **NCT02219971** · PHASE1 · COMPLETED · sponsor: **Tianjin Chasesun Pharmaceutical Co., LTD** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Kukoamine B Mesilate

## Key facts

- **NCT ID:** NCT02219971
- **Lead sponsor:** Tianjin Chasesun Pharmaceutical Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-05-06
- **Final completion:** 2015-05-06
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02219971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02219971, "Phase I Study of Kukoamine B Mesilate in Healthy Volunteers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02219971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*